Protamine sulfate

Why this drug is interesting

Protamine is one of the oldest antidotes still in routine use and one of the very few whose dose is a function of elapsed time. Every other reversal agent on this site is dosed on the patient — weight, INR, drug level. Protamine is dosed on the clock, because the thing it is neutralising is being cleared while you draw it up.

It is also the only drug here that is simultaneously the antidote and, at higher doses, the poison: "In gross excess, protamine itself acts as an anticoagulant."¹ Overdosing it to be safe makes the bleeding worse.

Pharmacology

Mechanism

Protamines are small, strongly basic polypeptides originally isolated from fish sperm. Heparin is a strongly acidic polyanion. The two form a stable, inactive ionic complex — the reversal is not enzymatic, receptor-mediated or metabolic, but simple charge neutralisation. This is why it works within minutes and why the stoichiometry is expressed as milligrams per unit of heparin rather than as a physiological endpoint.

The same electrostatic mechanism explains the incomplete reversal of low-molecular-weight heparin. LMWH's anti-Xa activity depends on shorter saccharide chains that bind protamine less avidly than the long chains responsible for anti-IIa activity. Protamine neutralises the anti-IIa effect well and the anti-Xa effect only partially.

Rebound bleeding

"A rebound bleeding effect may occur up to 18 hours post-operatively which responds to further doses of protamine."¹ Patients receiving repeated doses during prolonged procedures need careful monitoring of clotting parameters — this is a real, labelled phenomenon, not a theoretical one.

Dosing — unfractionated heparin

The base rule

1 mg of protamine sulfate will usually neutralise at least 100 international units of mucous heparin, or 80 units of lung heparin.¹ Almost all UK heparin is mucous (porcine intestinal), so 1 mg per 100 units is the working figure. The label's own pharmacology section is looser than its dosing section — section 5.1 gives the range as 80 to 120 units of heparin per milligram — which is a useful reminder that the 1:100 stoichiometry is an approximation, not a titration.¹

Give by slow intravenous injection over about 10 minutes, and never more than 50 mg in a single dose.¹

The time correction

The label states that the dose should be reduced if more than 15 minutes have elapsed since intravenous heparin, and gives two worked examples:¹

By route of heparin administration

IV infusion running

Stop the infusion, then give 25–50 mg by slow IV injection.¹ Note the label does not ask you to calculate from the infusion rate.

Subcutaneous heparin

1 mg per 100 units — but split it: 25–50 mg by slow IV injection and the balance by IV infusion over 8–16 hours, because absorption from the subcutaneous depot continues.¹

After cardiopulmonary bypass

Either a standard dose as above, or titrated to the activated clotting time.¹

Monitoring

Check an aPTT or ACT 5–15 minutes after protamine administration.¹ Further doses may be needed.

Dosing — low-molecular-weight heparin

"A dose of 1 mg per 100 units is usually recommended but the manufacturer's own guidelines should be consulted."¹ The label defers here, and so should you — enoxaparin, dalteparin and tinzaparin labels differ.

Two further LMWH-specific adjustments in the label:¹

• LMWH half-life is roughly twice that of unfractionated heparin, so the time-decay correction is slower. Theoretically the protamine dose should be halved once one half-life has elapsed since the last LMWH dose.
• For subcutaneous LMWH, intermittent injections or a continuous protamine infusion have been recommended, because absorption from the depot continues.

Hypersensitivity — the groups to ask about

Protamine causes hypersensitivity reactions including angioedema, anaphylactoid reactions and fatal anaphylaxis.¹ The SmPC names four populations at increased risk, and they are an unusual and easily-missed set:

• Previous exposure to protamine — anyone who has had coronary angioplasty or cardiopulmonary bypass.
• Diabetics treated with protamine insulin — isophane (NPH) and other protamine-containing insulins.
• Patients allergic to fish.
• Men who have had a vasectomy, or who are infertile — they may have antibodies to protamine.

Other adverse effects

Cardiac

Bradycardia

Vascular

Sudden fall in blood pressure; pulmonary and systemic hypertension; flushing and warmth; severe acute pulmonary vasoconstriction with cardiovascular collapse

Respiratory

Dyspnoea; rare non-cardiogenic pulmonary oedema with prolonged hypotension, with significant morbidity and mortality

Haematological

Anticoagulant effect at doses in excess of that needed to neutralise the heparin

Other

Nausea, vomiting, back pain, lassitude

Overdose and special populations

Too much protamine

Given without heparin, or in excess of the neutralising dose, protamine exerts its own anticoagulant effect.¹ Additional features are hypotension, bradycardia, dyspnoea, nausea, vomiting, lassitude and flushing. Treatment is supportive with coagulation monitoring; if bleeding is a problem, give fresh frozen plasma or fresh whole blood.¹

Children

"Safety and efficacy in children have not been established. Not recommended."¹ Protamine is nonetheless used in paediatric cardiac surgery and in paediatric heparin overdose; that use is unlicensed and should be discussed with a paediatric haematologist or the poisons service.

Elderly and pregnancy

No evidence for dose alteration in the elderly. In pregnancy, use only if clearly indicated; caution during lactation.¹ Contraindications: none known.

Practical use in the ED

1. Establish which heparin, what dose, and when. All three change the answer. If any is unknown, be guided by the aPTT or ACT.
2. Stop the heparin infusion first. For a running infusion the label's answer is simply 25–50 mg, not a calculation from the rate.
3. Calculate, then apply the time decay. 1 mg/100 units under 15 minutes; roughly half that at 30–60 minutes; roughly a quarter at 2 hours.
4. Cap the single dose at 50 mg and give it over about 10 minutes with the patient monitored and resuscitation drugs to hand.
5. Recheck aPTT or ACT at 5–15 minutes.
6. Warn the receiving team about rebound — up to 18 hours for surgical patients, and up to 24 hours of residual anti-Xa activity after LMWH.

Critical appraisal

Prosulf's SmPC is a 1990s document and reads like one: no contraindications, no interactions, no pharmacokinetic data worth the name, and dosing expressed in units of "mucous" and "lung" heparin — a distinction that has largely disappeared from UK practice. It has not been updated to reflect the modern reality that most heparin bleeding is low-molecular-weight, and its LMWH guidance defers entirely to other manufacturers.

Despite that, the core content is sound and unusually honest for its era: it tells you the reversal of LMWH is incomplete, it tells you protamine is itself an anticoagulant, it tells you rebound happens at 18 hours, and it names four hypersensitivity groups most clinicians could not list. The weakest part is the time-decay table, which is presented as a worked example rather than as validated pharmacokinetics — treat it as a starting estimate to be corrected by a coagulation test, which is what the label itself recommends.

References

1. 1
   Prosulf 10 mg/ml Solution for Injection (protamine sulfate) — Summary of Product Characteristics, Wockhardt UK Ltd. electronic Medicines Compendium, product 8. Sections 4.1–4.9. Source of the 1 mg/100 unit rule, the time-decay figures, the 50 mg ceiling, the 10-minute rate, the LMWH incomplete-reversal statement, the 18-hour rebound and the four hypersensitivity risk groups. Verified 31 Aug 2026; this was the only single-ingredient protamine product listed on the emc at that date.